Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,500
Closed -$232K 122
2022
Q2
$177K Sell
3,500
-22,214
-86% -$1.24M 0.03% 124
2022
Q1
$2.03M Buy
25,714
+1,248
+5% +$75.5K 0.27% 70
2021
Q4
$2.01M Hold
24,466
0.3% 63
2021
Q3
$3.34M Buy
24,466
+18,539
+313% +$3.16M 0.24% 94
2021
Q2
$1.33M Hold
5,927
0.11% 149
2021
Q1
$1.52M Buy
+5,927
New +$1.3M 0.05% 219

Other funds holding CLNN

Ikarian Capital's CLNN Position: Q3 2022 in Review

Ikarian Capital sold out of Clene (CLNN) in Q3 2022, closing a stake of 3,500 shares — an estimated $232K sold.

Ikarian Capital first reported a position in CLNN in Q1 2021 and held it in 6 quarters. The position peaked at $3.34M in Q3 2021. 38 funds tracked by Wall St. Rank hold CLNN as of Q3 2022.

  • Ikarian Capital reported no remaining Clene position as of Q3 2022 after selling out during the quarter.
  • Ikarian Capital sold 3,500 Clene shares in Q3 2022, an estimated $232K.
  • Ikarian Capital first reported a position in Clene in Q1 2021 and held it in 6 quarters.
  • Ikarian Capital's Clene position peaked at $3.34M in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Clene as of Q3 2022.

Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.